Skip to main content

Table 1 Clinical and demographic characteristics

From: The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study

Variable

Diabetes Patients

Health Professionals

Total

N (%)

N (%)

N (%)

Sex

 Male

10 (43.47)

8 (0.8)

18 (54.54)

 Female

13 (56.52)

2 (0.2)

15 (45.45)

Age Group

 20–40

4 (17.39)

9 (0.9)

13 (39.39)

 41–60

11 (47.82)

1 (0.1)

12 (36.36)

 60 and older

8 (34.78)

0 (0)

8 (24.24)

Marital Status

 Married

23 (100)

6 (0.6)

29 (87.87)

 Single

0 (0)

4 (0.4)

4 (12.12)

HbA1c level

 < 7.0%

5 (21.73)

  

  ≥ 7%

18 (78.26)

  

Education

 Illiterate

16 (69.56)

0 (0)

16 (48.48)

 Junior High School

3 (13.04)

0 (0)

3 (9.09)

 High School Diploma

3 (13.04)

0 (0)

3 (9.09)

 Associate Degree

1 (4.34)

3 (0.3)

4 (12.12)

 Bachelor’s Degree

0 (0)

4 (0.4)

4 (12.12)

 Master’s Degree

0 (0)

1 (0.1)

1 (3.03)

 PhD

0 (0)

2 (0.2)

2 (6.06)

Residence

 Urban

15 (65.21)

5 (50)

20 (60.60)

 Rural

8 (34.78)

5 (50)

13 (39.39)

T2DM History In 1st-Degree Relatives

 Yes

18 (78.26)

  

 No

5 (21.73)

  

Occupational Status

 Employed

4 (17.39)

  

 Retired

4 (17.39)

  

 Housewife

10 (43.47)

  

 Unemployed

5 (21.73)

  

Time Since Diagnosis

 < One Year

2 (8.69)

  

 1 to 5 Years

5 (21.73)

  

 > 5 Years

16 (69.56)

  

Household Income

 Inadequate to Cover Living Expenses

16 (69.56)

  

 Sufficient to Cover Living Expenses

7 (30.43)

  

Complications Of Diabetesa

 Yes

8 (34.78)

  

 No

15 (65.21)

  

Physical Activity

 Regular

5 (21.73)

  

 Irregular

8 (34.78)

  

 No Physical Activity

10 (43.47)

  

Drug Use And Smoking

 Yes

4 (17.39)

  

 No

19 (82.60)

  

Visit By Doctor

 Regular

14 (60.86)

  

 Irregular

9 (39.13)

  

Medications

 Metformin Only

8 (34.78)

  

 Metformin & Glibenclamide

8 (34.78)

  

 Metformin & Insulin

7 (30.43)

  
  1. a Having at least one microvascular (nephropathy, neuropathy and retinopathy) or cardiovascular (cardiovascular disease, stroke, peripheral artery disease and cerebrovascular disease) complication, hypertension & hyperlipidemia